Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 68 results for "national pharmaceutical pricing autho..."

Dr. Reddy's and NPPA battle at Delhi High Court over blood pre...

Dr. Reddy's has accused India's National Pharmaceutical Pricing Authority (NPPA) of incorrectly revising the ceiling price for the hypertension treatment amlodipine, as reported The Economic Times Tuesday. Specifically, Dr. Reddy's argued in ... FirstWord Pharma, 1 month ago

65 images for national pharmaceutical pricing authority

Deccan Chronicle, 1 month ago
Med India, 2 months ago
financialexpress.com, 2 months ago
Livemint.com, 1 week ago
International Business Times India, 3 weeks ago
India Infoline, 2 months ago
Firstpost.com, 2 months ago
Radio Pakistan, 4 days ago
The Japan News, 1 day ago
Hindustan Times, 3 months ago

Failure in controlling prices: NA panel displeased with DRAP performance

Home » Business & Economy » Pakistan July 22, 2016 The National Assembly Standing Committee on National Health Services, Regulations and Co-ordination on Thursday expressed displeasure over working and performance of Drug Regulatory Authority ...
 Business Recorder1 month ago NA body to resolve medicines pricing, quality issues  Pakistan Today1 month ago Increase in drug prices linked to CPI: official  Business Recorder1 month ago

Alexion Pharmaceuticals, Inc. (ALXN) CEO David Hallal on Q2 2016 Results - Earnings Call Transcript

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Q2 2016 Earnings Conference Call July 28, 2016 10:00 AM ET Executives Elena Ridloff - Vice President, Investor Relations David Hallal - Chief Executive Officer Vikas Sinha - Chief ...
 Seeking Alpha1 month ago Wabash National's (WNC) CEO Rick Giromini on Q2 2016 Results - Earnings Call Transcript  Seeking Alpha1 month ago

DoP rejects review application of Premium Serums on Specific Anti-Snake Venom Lyophilized Polyvalent Serum

The Department of Pharmaceuticals (DoP) has rejected the review application of Premium Serums & Vaccines Pvt. Ltd filed against fixing of ceiling price of Specific Anti-Snake Venom Lyophilized Polyvalent Serum by the National Pharmaceutical Pricing ...
 PharmaBiz1 month ago DoP rejects Pregna's review plea on 'Harmone Releasing IUD' for failing to file within 30 days  PharmaBiz1 month ago

New vaccine plant of Incepta inaugurated at Savar

A modern vaccine plant of Incepta Pharmaceuticals Limited was launched at Savar, on the outskirts of the capital, on Thursday. The health and family welfare minister, Mohammad Nasim, inaugurated the plant as chief guest. In a simple ceremony, ...
 New Age Bangladesh1 month ago
Financial Express

Govt working on regulating web pharmacy: Sitharaman

New Delhi, Jul 27 (PTI) The Health Ministry and Central Drugs Standard Control Organisation (CDSCO) are working to see how the online sale of medicines can be regulated, Rajya Sabha was informed today. The availability of essential medicines are ...
 Press Trust of India1 month ago "Govt working on regulating web pharmacy"  Press Trust of India1 month ago
[x]  

Glenmark Pharmaceuticals: Right prescription

The last year has not been a smooth one for pharma stocks. The BSE Healthcare Index has shed nearly 4 per cent during this period. This was due to the scrutiny by the US drug regulator on the manufacturing facilities of Indian drug makers and ...
 Hindu Business Line1 month ago

Vikram Sarabhai: India's last Renaissance Man?

New Delhi Title: Vikram Sarabhai - A Life; Author: Amrita Shah; Publisher: Penguin Books; Pages: 264; Price: Rs 399 Our relation with our scientists is curious - they are usually idolised to the point of near idolatry, their names adorn various ...
 ProKerala.com1 month ago Book Review: Vikram Sarabhai: India's last Renaissance Man?  India New England1 month ago
[x]  

Ligand Announces Multi-Program LTP Technology Licensing Agreement with Nucorion Pharmaceuticals

Jul. 29, 2016 08:30 AM Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the signing of a license agreement for three programs utilizing Ligand's LTP (Liver Targeting Prodrug) technology with Nucorion Pharmaceuticals, Inc., a ...
 Sys-Con Canada1 month ago
BayStreet.ca

Actinium Pharmaceuticals: Another Promising Name In The AML Space

While this has been a mixed year for the biotechnology sector, there have been some clear winners. Celator Pharmaceuticals Inc. (NASDAQ: CPXX) is one such winner. In fact, CPXX is one of the most phenomenal stories in the biotech sector this year.
 BayStreet.ca1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - national pharmaceutical pricing authority
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
Happening by Location Click on any location on map to view latest news by location
 
More     Less